Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection

Circulation

Volumn 105, Issue 11, 2002, Pages 1298-1303

  Parchure, Nikhil ^a   Zouridakis, Emmanouil G ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cell adhesion molecules; Endothelium; Infection; Von Willebrand factor

Indexed keywords

AZITHROMYCIN; BACTERIUM ANTIBODY; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PLACEBO; VON WILLEBRAND FACTOR;

ADULT; ANTIBIOTIC THERAPY; ANTIBODY TITER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; ATHEROGENESIS; BRACHIAL ARTERY; CELL FUNCTION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; AZITHROMYCIN; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CHLAMYDOPHILA INFECTIONS; CORONARY ARTERIOSCLEROSIS; DOUBLE-BLIND METHOD; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEROLOGIC TESTS; TREATMENT OUTCOME; VASCULAR PATENCY; VASODILATION; VON WILLEBRAND FACTOR;

EID: 0037133588     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc1102.105649     Document Type: Article

References (24)

1. Atherosclerosis: An inflammatory disease
2. Chronic infections and coronary heart disease: Is there a link?
3. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis
4. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
5. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease
6. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
7. Infection, inflammation and infarction: Does acute endothelial dysfunction provide a link?
8. Acute systemic inflammation impairs endothelium-dependent dilatation in humans
9. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae
10. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice
11. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
12. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
13. Growth of Chlamydia psittaci in macrophages
14. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappa B and induces tissue factor and PAI-1 expression: A potential link to accelerated arteriosclerosis
15. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity
16. Interactions of Chlamydia pneumoniae with human endothelial cells
17. Respiratory infection in lipid-fed rabbits enhances sudanophilia and the expression of VCAM-1
18. The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease
19. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction
20. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study
21. Anti-inflammatory activity of macrolides: A new therapeutic potential?
22. Anti-inflammatory activity of macrolide antibiotics
23. Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: Enhancement by a 14-membered ring macrolide
24. Membrane-stabilizing, antiinflammatory interactions of macrolides with human neutrophils